Skip to Content

MD Anderson Events

Hematology Grand Rounds

Hematology Grand Rounds

 

Department of Lymphoma/Myeloma
In Collaboration with the
Department of Leukemia and Department of Stem Cell Transplantation
 
 
Eduardo M. Sotomayor, M.D.
Moffitt Cancer Center and Research Institute
 
 
Presenting
 
“Targeting Specific Histone Deacetylases in B-cell Malignancies”
 
Wednesday, April 30, 2014
8:00 a.m. – 9:00 a.m.
Pickens Tower, 3rd Floor, Rooms 1, 2, 7 & 8
 
After attending this activity, the target audience of Physicians from Leukemia, Lymphoma/Myeloma, Stem Cell Transplantation and Research Staff, Nurses, Data Coordinators, Laboratory Staff, Post-Doctoral Fellows, Instructors, and Research Staff in Lab should be able to:
 
  • Assess clinical and translational research in lymphoma and plasma cell dyscrasia (knowledge);
  • Increase collaboration between disciplines regarding lymphoma and plasma cell dyscrasia (knowledge, competence, performance);
  • Update knowledge and collaboration in trials and research (knowledge, competence, performance);
  • Accelerate the speed of translational research and clinical trials to achieve better patient outcomes (knowledge, competence, performance, patient outcomes);
 
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of The University of Texas MD Anderson Cancer Center that the program chair(s), planning committee member, faculty/teacher/ author, or CME activity reviewer must disclose any relevant financial relationships with commercial interests whose products may be discussed in the activities, if any.  MD Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products.  Specific disclosure will be made to the participants prior to the educational activity.               

Date: 4/30/14, 8am to 9am
Time: 4/30/14, 8am to 9am
Location: Pickens Academic Tower, Floor 3, Room 3 (FCT3.4143)
Format: All Employee Meeting
CME: 1.0
Facilitator: Laura Lam, PhD
Speaker: Eduardo Sotomayor, M.D.
Speaker Bio: Eduardo M. Sotomayor, MD is the Susan and John Sykes Endowed Chair in Hematologic Malignancies at Moffitt Cancer Center and Professor of Oncologic Sciences and of Pathology and Cell Biology at the University of South Florida College of Medicine in Tampa, Florida. He is also the Scientific Director of the DeBartolo Personalized Medicine Institute at Moffitt Cancer Center. Dr. Sotomayor received his MD degree from Federico Villarreal National University School of Medicine in Lima, Peru, before completing his residency in Internal Medicine at Jackson Memorial Hospital/University of Miami School of Medicine in Florida. He then trained as Medical Oncologist at Johns Hopkins University in Baltimore, Maryland. His research interest is in the area of immunobiology and immunotherapy of B-cell malignancies. His clinical interest lies particularly with mantle cell lymphoma. He has published close to 100 manuscripts including seminal publications in top tier journals such as Nature Medicine, Nature Immunology, Immunity, Cancer Cell, Proceedings of the National Academy of Sciences, Journal of Clinical Investigations, Blood, Cancer Research and Journal of Immunology. He currently has three NIH R01 grants and has received several grants in the past from the Lymphoma Research Foundation (LRF). He is a member of the Scientific Advisory Board, Lymphoma Research Foundation, a member of the Mantle Cell Lymphoma Consortium and a standing Member, National Cancer Institute, Subcommittee A (Parent Committee), Cancer Centers.
Contact: Curtisha Jones - (713) 745-8168 - cljones1@mdanderson.org